Where does Bonraybio Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bonraybio Co., Ltd. ranks #13,892 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bonraybio Co., Ltd. hold?

Bonraybio Co., Ltd. holds 21 US utility patents granted between 2017 and 2024, spanning 13 technology areas.

What is Bonraybio Co., Ltd.'s Innovation Score?

Bonraybio Co., Ltd. has an Innovation Score of 37.6 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bonraybio Co., Ltd. focus on?

Bonraybio Co., Ltd.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 14 patents, ranking #1,082 of 7,863 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Bonraybio Co., Ltd.'s patent grant rate increasing or decreasing?

Bonraybio Co., Ltd.'s recent grant velocity is -9% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bonraybio Co., Ltd.'s patents?

Bonraybio Co., Ltd.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bonraybio Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bonraybio Co., Ltd.

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bonraybio ranks #13,892 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#13,892
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.6/100): 15.3
avg claims per patent: -9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13892 · Foreign Corporation #13,892 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,892/49,997
PHOTO-FINISH Bio2 Medical
CPC-FOCUS G01N · 13 areas
INNOV-THIN 37.6/100
CLAIMS-RICH 15.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bio2 Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bonraybio’s 37.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (28%) Velocity 5.0 pts (13%) Breadth 12.7 pts (34%) Claim depth 9.2 pts (24%)

Qualcomm Incorporated · highest

85
Bonraybio · this assignee

38
3D Lighting… · lowest

7

What this shows Bonraybio's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bonraybio?

Each dot is one of Bonraybio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bonraybio’s own 15.3 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bonraybio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bonraybio's grants concentrate

Bonraybio Co., Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2017. By volume, Bonraybio sits between Bio2 Medical, Inc. and Bretford Manufacturing, Inc..

Bonraybio's three-year grant acceleration

Bonraybio Co., Ltd. shows 6 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bio2 Medical

21
Biokine Therapeut…

21
Biolitec Unterneh…

21
Bitly

21
Bovie Medical

21
Brainwave Research

21
Branson Ultrascha…

21
Bretford Manufact…

21
Bonraybio ◀

21

What this shows Bonraybio holds 21 patents at rank #13,894, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bonraybio

By rank, the assignees closest to #13,894 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Bonraybio's primary technology class.

Bonraybio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Bonraybio Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	4.8%
2018	6	28.6%
2019	4	19.0%
2020	1	4.8%
2021	3	14.3%
2022	1	4.8%
2023	2	9.5%
2024	3	14.3%

Which technologies does Bonraybio Co., Ltd. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

G02B - Optical Elements, Systems OR Apparatus 10

G06T - Image Data Processing OR Generation, IN General 9

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 6

H04N - Pictorial Communication, e.g. Television 6

A61B - DIAGNOSIS; SURGERY; Identification 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G06V - Image OR Video Recognition OR Understanding 2

G06F - Electric Digital Data Processing 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01G - Weighing 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bonraybio Co., Ltd.'s patent record in context - here's where to go next.

Bonraybio Co., Ltd.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 66.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #13,892 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bonraybio Co., Ltd. against Bio2 Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.